New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Money troubles can delay cancer diagnoses, putting survival in jeopardy

Money troubles can delay cancer diagnoses, putting survival in jeopardy

by Alan MozesMoney woes have long been linked to worse health care. Now, a new study finds financially strapped patients often put off cancer screenings—only to learn they have the disease when it&#39
World medicine December 10,2023
Money troubles can delay cancer diagnoses, putting survival in jeopardy

Money troubles can delay cancer diagnoses, putting survival in jeopardy

by Alan MozesMoney woes have long been linked to worse health care. Now, a new study finds financially strapped patients often put off cancer screenings—only to learn they have the disease when it&#39
World medicine December 10,2023
Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability

Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability

by Impact Journals LLCFigure 1: Mechanisms of MCL-1 inhibitor-induced MCL-1 protein upregulation, stability, and induction of apoptosis. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.2
World medicine December 10,2023
Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability

Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability

by Impact Journals LLCFigure 1: Mechanisms of MCL-1 inhibitor-induced MCL-1 protein upregulation, stability, and induction of apoptosis. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.2
World medicine December 10,2023
Addressing cancer concerns in the LGBTQ+ community

Addressing cancer concerns in the LGBTQ+ community

by Deb BalzerCredit: Pixabay/CC0 Public DomainDuring June, many cities and towns around the U.S. and the world celebrate and raise awareness of the LGBTQ+ community's accomplishments and the ongoi
World medicine December 10,2023
Addressing cancer concerns in the LGBTQ+ community

Addressing cancer concerns in the LGBTQ+ community

by Deb BalzerCredit: Pixabay/CC0 Public DomainDuring June, many cities and towns around the U.S. and the world celebrate and raise awareness of the LGBTQ+ community's accomplishments and the ongoi
World medicine December 10,2023
Deconstructing the role of MALAT1 in MAPK-signaling in melanoma

Deconstructing the role of MALAT1 in MAPK-signaling in melanoma

by Impact Journals LLCMALAT1-ASO specifically targets MALAT1-lncRNAs. (A) Schematic illustration of the MALAT1-ASO bypassing the cell-membrane and entering the nucleus of melanoma cells to inhibit MAL
World medicine December 10,2023
Deconstructing the role of MALAT1 in MAPK-signaling in melanoma

Deconstructing the role of MALAT1 in MAPK-signaling in melanoma

by Impact Journals LLCMALAT1-ASO specifically targets MALAT1-lncRNAs. (A) Schematic illustration of the MALAT1-ASO bypassing the cell-membrane and entering the nucleus of melanoma cells to inhibit MAL
World medicine December 10,2023
Deciphering progesterone's mechanisms of action in breast cancer

Deciphering progesterone's mechanisms of action in breast cancer

by Impact Journals LLCAn integrated representation of the multifaceted effects of progesterone in breast cancer. A schematic representation to describe the molecular mechanisms by which progesterone a
World medicine December 10,2023
Deciphering progesterone's mechanisms of action in breast cancer

Deciphering progesterone's mechanisms of action in breast cancer

by Impact Journals LLCAn integrated representation of the multifaceted effects of progesterone in breast cancer. A schematic representation to describe the molecular mechanisms by which progesterone a
World medicine December 10,2023
Gains in colorectal cancer outcomes slowing, reversing

Gains in colorectal cancer outcomes slowing, reversing

by Lori SolomonDecreases in colorectal cancer (CRC) diagnoses and deaths among adults in their 50s and 60s have slowed compared with previous decades, according to a study recently published inC
World medicine December 10,2023
Gains in colorectal cancer outcomes slowing, reversing

Gains in colorectal cancer outcomes slowing, reversing

by Lori SolomonDecreases in colorectal cancer (CRC) diagnoses and deaths among adults in their 50s and 60s have slowed compared with previous decades, according to a study recently published inC
World medicine December 10,2023
Genetic switch turns tumor suppressor into oncogene in colorectal cancer

Genetic switch turns tumor suppressor into oncogene in colorectal cancer

by Liana F. Wait,University of PennsylvaniaInhibiting the enzyme NOTUM slowed cancer growth and prevented metastasis in an animal model of colorectal cancer. Credit: Yuhua TianColorectal cancer
World medicine December 10,2023
Genetic switch turns tumor suppressor into oncogene in colorectal cancer

Genetic switch turns tumor suppressor into oncogene in colorectal cancer

by Liana F. Wait,University of PennsylvaniaInhibiting the enzyme NOTUM slowed cancer growth and prevented metastasis in an animal model of colorectal cancer. Credit: Yuhua TianColorectal cancer
World medicine December 10,2023
Colorectal cancer patients may benefit from breakthrough EU research

Colorectal cancer patients may benefit from breakthrough EU research

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: Pixabay/CC0 Public DomainScientists in Spain have developed a potentially life-saving strategy against a disease that sp
World medicine December 10,2023
Colorectal cancer patients may benefit from breakthrough EU research

Colorectal cancer patients may benefit from breakthrough EU research

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: Pixabay/CC0 Public DomainScientists in Spain have developed a potentially life-saving strategy against a disease that sp
World medicine December 10,2023
Combining epigenetic and metabolic approaches for targeted cancer treatment

Combining epigenetic and metabolic approaches for targeted cancer treatment

by Olivia Dimmer,Northwestern UniversityCredit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI169993Northwestern Medicine scientists have identified a novel vulnerability i
World medicine December 10,2023
Combining epigenetic and metabolic approaches for targeted cancer treatment

Combining epigenetic and metabolic approaches for targeted cancer treatment

by Olivia Dimmer,Northwestern UniversityCredit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI169993Northwestern Medicine scientists have identified a novel vulnerability i
World medicine December 10,2023
Outcome indicators make quality of life after childhood cancer measurable

Outcome indicators make quality of life after childhood cancer measurable

by Princess Máxima Center for Pediatric OncologyInternational Childhood Cancer Core Outcome Set. Credit:Nature Medicine(2023). DOI: 10.1038/s41591-023-02339-yA new measurement tool helps a
World medicine December 10,2023
Outcome indicators make quality of life after childhood cancer measurable

Outcome indicators make quality of life after childhood cancer measurable

by Princess Máxima Center for Pediatric OncologyInternational Childhood Cancer Core Outcome Set. Credit:Nature Medicine(2023). DOI: 10.1038/s41591-023-02339-yA new measurement tool helps a
World medicine December 10,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com